Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 108
Filter
1.
Oncol. (Guayaquil) ; 31(1): 46-55, Abril 30, 2021.
Article in Spanish | LILACS | ID: biblio-1222458

ABSTRACT

Introducción: Dentro de las cinco primeras neoplasias en el mundo están las Leucemias, la misma que ha venido incrementándose en las últimas décadas. El objetivo del presente estudio fue determi-nar las características epidemiológicas de las Neoplasias del tejido Hematopoyético y linfoide en pacientes atendidos en el Instituto Oncológico Nacional-SOLCA Guayaquil durante los años 2015 al 2019. Metodología: Se efectuó un estudio de diseño observacional, descriptivo poblacional; donde el universo y la muestra fueron 891 casos nuevos de neoplasias del Tejido Hematopoyético y Linfoide, recolectándose los datos en una matriz, que fueron tomados del programa informático del registro de tumores. Resultados: se diagnosticaron Leucemias Linfoideas (69.58%) y Leucemias Mieloides (30.30%); más en hombres (53.33%) que mujeres (44.67%); siendo los casos en menores de 19 años en Gua-yaquil del 57.33% y en Otras ciudades con el 64.36%; en Guayaquil el grupo de edad de 5 ­ 9 años fue más frecuente con 20.57% seguido de los menores de 5 años con 19.02%; mientras que en Otras ciudades fueran los menores de 5 años con 20.72% seguido del grupo etario de 5 ­ 9 años con 18.33%; entre otros grupos. Su mayor frecuencia en Guayaquil fueron en parroquias Tarqui, Ximena y en Otras ciudades en Región Costa (81.47%). Conclusión: Dentro de las neoplasias del Tejido Hematopoyético y Linfoide la más común fue las Leucemias Linfoideas en la población menor de 19 años con énfasis en los niños menores de 5 años mostrando una presencia importante en los años de estudio en Guayaquil y en la región Costa del Ecuador.


Introduction: Leukemias are among the first five neoplasms in the world, the same one that has been increasing in recent decades. The aim of this study was to determine the epidemiological char-acteristics of Hematopoietic and Lymphoid Neoplasms in patients treated at the National Oncological Institute-SOLCA Guayaquil during the years 2015 to 2019. Methodology: An observational, descriptive population study was carried out; Where the universe and the sample were 891 new cases of Hematopoietic and Lymphoid neoplasms, the data was col-lected in a matrix, taken from the tumor registry computer program. Results: Lymphoid Leukemias were diagnosed in 69.58% and Myeloid Leukemias with 30.30%; more in men (53.33%) than women (44.67%); being the cases in minors of 19 years in Guayaquil 57.33% and in Other cities it had 64.36%; in Guayaquil the age group of 5 - 9 years was more frequent with 20.57% followed by those under 5 years with 19.02%; while in Other cities under 5 years old with 20.72% followed by the age group of 5 - 9 years old with 18.33%; among other groups. Its highest frequency in Guayaquil was in Tarqui and Ximena parishes and in other cities it was in the Coastal Region with 81.47%. Conclusion: Among the Hematopoietic and Lymphoid neoplasms the most common was Lym-phoid Leukemias in the population under 19 years of age, with emphasis on children under 5 years of age, showing an important presence in the years of study in Guayaquil and in the Ecuadorian Coastal region.


Subject(s)
Leukemia , Hematologic Neoplasms , Health Services Research , Epidemiology , Hematopoietic System
2.
Journal of Experimental Hematology ; (6): 1478-1484, 2021.
Article in Chinese | WPRIM | ID: wpr-922282

ABSTRACT

OBJECTIVE@#To investigate the toxic damage and possible mechanism of chronic exposure of ambient particulate matter (PM@*METHODS@#Mice were treated with different doses (150, 300, 600 mg/kg) of chitosan after exposure to PM@*RESULTS@#Compared with the mice in control group, IL-2 secretion and CXCL12 expression were decreased in the bone marrow of PM@*CONCLUSION@#Chronic exposure of PM


Subject(s)
Animals , Bone Marrow , Chitosan , Hematopoietic Stem Cell Transplantation , Hematopoietic System , Mice , Particulate Matter/toxicity
3.
Article in Chinese | WPRIM | ID: wpr-880178

ABSTRACT

OBJECTIVE@#To analyze and predict the effect of coronavirus infection on hematopoietic system and potential intervention drugs, and explore their significance for coronavirus disease 2019 (COVID-19).@*METHODS@#The gene expression omnibus (GEO) database was used to screen the whole genome expression data related with coronavirus infection. The R language package was used for differential expression analysis and KEGG/GO enrichment analysis. The core genes were screened by PPI network analysis using STRING online analysis website. Then the self-developed apparent precision therapy prediction platform (EpiMed) was used to analyze diseases, drugs and related target genes.@*RESULTS@#A database in accordance with the criteria was found, which was derived from SARS coronavirus. A total of 3606 differential genes were screened, including 2148 expression up-regulated genes and 1458 expression down-regulated genes. GO enrichment mainly related with viral infection, hematopoietic regulation, cell chemotaxis, platelet granule content secretion, immune activation, acute inflammation, etc. KEGG enrichment mainly related with hematopoietic function, coagulation cascade reaction, acute inflammation, immune reaction, etc. Ten core genes such as PTPRC, ICAM1, TIMP1, CXCR5, IL-1B, MYC, CR2, FSTL1, SOX1 and COL3A1 were screened by protein interaction network analysis. Ten drugs with potential intervention effects, including glucocorticoid, TNF-α inhibitor, salvia miltiorrhiza, sirolimus, licorice, red peony, famciclovir, cyclosporine A, houttuynia cordata, fluvastatin, etc. were screened by EpiMed plotform.@*CONCLUSION@#SARS coronavirus infection can affect the hematopoietic system by changing the expression of a series of genes. The potential intervention drugs screened on these grounds are of useful reference significance for the basic and clinical research of COVID-19.


Subject(s)
COVID-19 , Computational Biology , Follistatin-Related Proteins , Hematopoietic System , Humans , Pharmaceutical Preparations , SARS-CoV-2
4.
Journal of Experimental Hematology ; (6): 1177-1182, 2020.
Article in Chinese | WPRIM | ID: wpr-827143

ABSTRACT

OBJECTIVE@#To investigate the mechanism of hematopoietic reconstruction in mice treated with Danggui Buxue Decoction (DBD) combined with the muscle-derived stem cell transplantation (MDSCT).@*METHODS@#Female Kunming mice were randomly divided into the 6 groups: irradiation model, the bone marrow transplantation, the MDSC transplantation, the DBD 1 (4.5 g/kg), 2 (13.5 g/kg), and 3 (22.5 g/kg) + MDSC transplantation. After a week of oral administration of normal saline or different doses of DBD, The mice were exposied to 8 Gy Cs γ ray and were followed by bone marrow or MDSC transplantation. The expression levels of Notch1, Jagged1 and Hes1 in bone marrow, thymus and spleen were measured at 3 and 8 weeks after irradiation and transplantation.@*RESULTS@#In the bone marrow, 3 weeks after above-mentioned treatment, the expression of Notch1 mRNA increased obviously and the expression of Jagged1, Hes1 mRNA decreased obviously in each intervention group, compared with the irradiation model group. 8th week after treatment, the expression of Notch1 mRNA decreased obviously in each intervention group, the Jagged1 mRNA expression decreased obviously except the bone marrow group, and Hes1 mRNA expression increased (P<0.05) in each intervention group. 3 weeks after treatment, compared with the irradiation model group, the expression of Notch1 mRNA in the thymocytes increased only in DBD1+MDSC group, Jagged1, Hes1 mRNA was increased in the MDSC transplantation group and the DBD1、2+MDSC group. 8th week after treatment, the expression of Notch1, Jagged1 mRNA expression decreased in each intervention group, the expression of Hes1 mRNA increased obviously in the MDSC transplantation group and the DBD1、2+MDSC group (P<0.05). In the spleen, 3 weeks after treatment, the expression of Notch1, Jagged1 mRNA in the spleen of each intervention group decreased obviously, compared with the irradiation model group. The expression of Jagged1, Hes1 mRNA in each intervention group were increased obviously 8th week after treatment (P<0.05).@*CONCLUSION@#MDSC transplantation after pretreatment of DBD can improve the hematopoietic reconstitution in mice with lethal dose radiation damage. Notch1、Jagged1 and Hes1 play different roles in this process, but the concrete mechanism needs to be further studied.


Subject(s)
Animals , Drugs, Chinese Herbal , Female , Hematopoietic Stem Cell Transplantation , Hematopoietic System , Mice , Spleen
5.
Edumecentro ; 11(4): 122-135, oct.-dic. 2019.
Article in Spanish | LILACS | ID: biblio-1089978

ABSTRACT

RESUMEN Fundamento: la educación superior efectúa transformaciones profundas que se convierten en un factor clave para la puesta en marcha de procesos necesarios en el enfrentamiento a los desafíos del mundo existente. Objetivo: elaborar un material didáctico para la enseñanza aprendizaje del sistema hemolinfopoyético, con énfasis en el extendido de sangre periférica en la carrera de Bioanálisis Clínico. Métodos: se realizó un estudio descriptivo transversal en el período septiembre 2017-febrero 2018, en la Facultad Tecnológica "Octavio de la Concepción y de la Pedraja" de la Universidad de Ciencias Médicas "Carlos J. Finlay", de Camagüey. Se emplearon métodos teóricos: analítico-sintético e inductivo-deductivo; empíricos: observación a clases, la encuesta en forma de entrevista a docentes y la prueba exploratoria a estudiantes; y matemático-estadísticos para el cálculo de las frecuencias absolutas y el porcentaje. El producto fue valorado por criterios de especialistas. Resultados: se evidenciaron insuficiencias en el proceso enseñanza aprendizaje por los profesores para trabajar de manera integrada los procesos cognitivos sobre extendidos de sangre periférica como una vía para analizar las células hematopoyéticas; entre los estudiantes primaron el uso incorrecto de técnicas y procederes en los análisis y en la elaboración de los informes a partir de la observación e interpretación de extendidos de sangre periférica como componente esencial de la Hematología. Conclusiones: se elaboró un material didáctico que fue valorado por criterios de especialistas en las categorías de muy adecuado y adecuado en todos los indicadores propuestos, por lo que se consideró factible de ser aplicado.


ABSTRACT Background: Higher education carries out profound transformations that become a key factor for the implementation of necessary processes in the face of world challenges. Objective: to develop a teaching aid for the teaching - learning of the hemolinfopoietic system, with emphasis on the spread of peripheral blood in the Clinical Bioanalysis degree. Methods: a descriptive cross-sectional study was carried out from September 2017-to February 2018, at the "Octavio de la Concepción y de la Pedraja" Technological Faculty of the "Carlos J. Finlay" Camagüey University of Medical Sciences. Theoretical methods were used: analytical-synthetic and inductive-deductive; Empirical ones: observation to classes, the survey in the form of teacher interviews and the exploratory test to students; and mathematical-statistics for the calculation of the absolute frequencies and the percentage. The product was valued by criteria of specialists. Results: inadequacies in the teaching-learning process were evidenced by teachers to work in a comprehensive way on the cognitive processes on peripheral blood as a way to analyze hematopoietic cells; Among the students, the incorrect use of techniques and procedures prevailed in the analysis and in the preparation of the reports based on the observation and interpretation of peripheral blood spreads as an essential component of Hematology. Conclusions: a teaching aid was developed that was assessed by criteria of specialists in the categories of very adequate and adequate in all the proposed indicators, so it was considered feasible to be applied.


Subject(s)
Education, Medical , Hematology , Hematopoietic System , Laboratories
6.
Immune Network ; : e12-2019.
Article in English | WPRIM | ID: wpr-740216

ABSTRACT

Hematopoietic stem cells (HSCs) in bone marrow are pluripotent cells that can constitute the hematopoiesis system through self-renewal and differentiation into immune cells and red blood cells. To ensure a competent hematopoietic system for life, the maintenance of HSCs is tightly regulated. Although autophagy, a self-degradation pathway for cell homeostasis, is essential for hematopoiesis, the role of autophagy key protein Atg5 in HSCs has not been thoroughly investigated. In this study, we found that Atg5 deficiency in hematopoietic cells causes survival defects, resulting in severe lymphopenia and anemia in mice. In addition, the absolute numbers of HSCs and multiple-lineage progenitor cells were significantly decreased, and abnormal erythroid development resulted in reduced erythrocytes in blood of Vav_Atg5(−/−) mice. The proliferation of Lin⁻Sca-1⁺c-Kit⁺ HSCs was aberrant in bone marrow of Vav_Atg5(−/−) mice, and mature progenitors and terminally differentiated cells were also significantly altered. Furthermore, the reconstitution ability of HSCs in bone marrow chimeric mice was significantly decreased in the presence of Atg5 deficiency in HSCs. Mechanistically, impairment of autophagy-mediated clearance of damaged mitochondria was the underlying cause of the HSC functional defects. Taken together, these results define the crucial role of Atg5 in the maintenance and the reconstitution ability of HSCs.


Subject(s)
Anemia , Animals , Autophagy , Bone Marrow , Erythrocytes , Hematopoiesis , Hematopoietic Stem Cells , Hematopoietic System , Homeostasis , Lymphopenia , Mice , Mitochondria , Stem Cells
7.
Article in English | WPRIM | ID: wpr-785836

ABSTRACT

Space traveling is imperative for mankind in the future. Expectedly, hibernation will become an option for space traveler to overcome the endless voyage. With regard to some of the studies pointed out that during hibernation, muscle will undergo atrophy and meantime neurogenesis will reduce, these obstacles were frequently related with stem cell regeneration. Thus, investigation on whether hibernation will lead to dysfunction of stem cell becomes an important issue. By going through four main systems in this article, such as, hematopoietic system, skeletal muscle system, central nervous system and orthopedic system, we are expecting that stem cells regeneration capacity will be affected by hibernation. To date, these researches are majorly the read-out from short term or seasonal hibernating mammals. Proposing and creating a simulated long-term hibernation animal model is turning essential for the further investigation on the effect of longer period of hibernation to human stem cells.


Subject(s)
Adult Stem Cells , Adult , Arousal , Atrophy , Central Nervous System , Hematopoietic System , Hibernation , Humans , Mammals , Models, Animal , Muscle, Skeletal , Neurogenesis , Orthopedics , Regeneration , Seasons , Stem Cells , Torpor
8.
S. Afr. med. j. (Online) ; 109(8): 46-52, 2019.
Article in English | AIM, AIM | ID: biblio-1271229

ABSTRACT

The growing need for haematopoietic stem cell transplantation (HSCT) is reflected in the increasing number of transplants performed globally each year. HSCT provides life-changing and potentially curative therapy for a range of pathologies including haematological malignancies; other indications include certain congenital and acquired disorders of the haematopoietic system, autoimmune conditions and hereditary diseases. The primary goals of HSCT are either to replace haematopoietic stem and progenitor cells (HSPC) following myeloablative chemotherapy or to cure the original pathology with allogeneic HSPCs. Success depends on optimal outcomes at various stages of the procedure including mobilisation of marrow stem/progenitor cells for harvesting from the patient or donor, long-term and sustainable engraftment of these cells in the recipient, and prevention of graft-versus-host disease in the case of allogeneic HSCT. Challenges in South Africa include high cost, limited infrastructure and lack of appropriately trained staff, as well as limitations in securing suitable haematopoietic stem cell donors. This review aims to provide an overview of HSCT and some of the challenges that are faced in the South African context


Subject(s)
Current Procedural Terminology , Forecasting , Hematopoietic System , South Africa , Stem Cell Niche , Stem Cell Transplantation
9.
S. Afr. med. j. (Online) ; 109(8): 65-70, 2019. ilus
Article in English | AIM, AIM | ID: biblio-1271232

ABSTRACT

Autologous and allogeneic haematopoietic stem cell (HSC) transplantation has been performed in patients with various malignant and non-malignant haematological disorders for more than 50 years. Ex vivo gene modification of HSCs for autologous transplantation opens up new therapeutic avenues for genetic and infectious diseases. Major advances have been made over the last three decades with respect to gene modification of HSCs and transplantation strategies, ultimately culminating in the approval of two such therapies in Europe (Strimvelis for a rare primary immune deficiency, and LentiGlobin for beta-thalassaemia). Newer gene-modifying technologies and treatment regimens have also recently come to the fore, which hold great promise for the development of safer and more effective treatments. We provide an overview of the current state of gene-modified HSC therapies, highlighting success stories, limitations and important considerations for achieving successful translation of these therapies to the clinic


Subject(s)
Clinical Laboratory Services , Hematopoietic Stem Cells , Hematopoietic System , Medical Informatics Applications , South Africa , Stem Cell Transplantation
10.
Article in English | WPRIM | ID: wpr-715188

ABSTRACT

Mastocytosis is a rare disease which occurs in both children and adults, and it can manifest as a solitary or multiple skin lesions. Both can cause cutaneous or systemic symptoms. Because of the heterogeneity of clinical presentation of mastocytosis and its rare prevalence, it can be hard to suspect the mastocytosis at the first time. Most solitary mastocytomas are about 1–5 cm in diameter and have features of brownish-yellow, minimally elevated plaques with a smooth shiny surface. This article presents a case of solitary mastocytoma which occurred in neonate and that we treated through surgical excision. In histopathological examination, it consisted of c-kit-positive mast cells. Although pediatric cutaneous mastocytosis might regress spontaneously, clinicians should keep in mind that it could be associated with systemic mastocytosis which involves hematopoietic system.


Subject(s)
Adult , Child , Hematopoietic System , Humans , Infant, Newborn , Mast Cells , Mastocytoma , Mastocytosis , Mastocytosis, Cutaneous , Mastocytosis, Systemic , Parturition , Population Characteristics , Prevalence , Rare Diseases , Skin
11.
Article in Chinese | WPRIM | ID: wpr-272472

ABSTRACT

The sex-determining region Y-box 7 (Sox7) is a important member of SOX family containing high mobi- lity group (HMG), mapped to human chromosome 8p23.1. Wnt/β-catenin signaling pathway plays an important role in cell survival, differentiation, self-renewal, proliferation and apoptosis, and is closely related with carcinogenesis. SOX7 gene is likely to be a tumor suppressor gene in MDS and other hematological malignancies. As a negative regulator of the WNT/β-catenin signaling pathway, the function loss of this gene can lead to carcinogenesis. The methylation of SOX7 gene leads to the silence of this gene, resulting in tumorigenesis. The decision of hematopoietic stem cells to self-renew or differentiate is a stochastic process, but SOX7 can promote the differentiation into all blood cell types. This review focuses on the role of SOX7 in hematopoietic system development and hematological malignancies.


Subject(s)
DNA Methylation , Gene Silencing , Hematologic Neoplasms , Genetics , Metabolism , Hematopoietic System , Humans , SOXF Transcription Factors , Genetics , Metabolism , Wnt Signaling Pathway
12.
Blood Research ; : 200-203, 2016.
Article in English | WPRIM | ID: wpr-209252

ABSTRACT

BACKGROUND: Since cell turnover in the hematopoietic system constitutes a major source of uric acid (UA) production, we investigated whether hematopoietic stem cell transplantation (HSCT) is associated with significant changes in serum UA levels in patients with hematological disorders. METHODS: Patients who underwent HSCT at our institution between 2001 and 2012 were retrospectively enrolled. Serum UA levels at 3 months before, 1 week before, and 3 months and 1 year after HSCT were examined. RESULTS: Complete clinical and laboratory information including data regarding UA levels was available for 93 patients. At baseline, the mean UA level was 4.9±2.1 mg/dL, with an overall prevalence of hyperuricemia of 15% (defined as serum UA>6.8 mg/dL). Mean UA levels tended to be higher in patients with acute myeloid leukemia (4.8±2.0 mg/dL) and non-Hodgkin lymphoma (5.1±2.3 mg/dL) and lower in patients with aplastic anemia (mean, 4.2±1.8 mg/dL). UA levels dropped during myeloablative conditioning, reaching a nadir on the day of HSCT (3.27±1.4 mg/dL). Over the 3 months following HSCT, UA levels rose sharply (5.0±2.1 mg/dL) and remained stable up to 1 year after HSCT (5.5±1.6 mg/dL). UA levels in HSCT recipients at 12 months correlated with those of their respective graft donors (Pearson r=0.406, P=0.001). CONCLUSION: HSCT is associated with significant changes in uric acid levels in patients with hematologic disorders.


Subject(s)
Anemia, Aplastic , Bone Marrow , Cohort Studies , Hematopoietic Stem Cell Transplantation , Hematopoietic System , Humans , Hyperuricemia , Leukemia, Myeloid, Acute , Lymphoma, Non-Hodgkin , Prevalence , Retrospective Studies , Stem Cell Transplantation , Stem Cells , Tissue Donors , Transplants , Uric Acid
13.
ARS med. (Santiago, En línea) ; 41(2): 50-53, 2016. Tab
Article in Spanish | LILACS | ID: biblio-1016204

ABSTRACT

El trasplante hematopoyético es una estrategia terapéutica que permite posibilidad de curación en diversas enfermedades benignas y malignas. El autotrasplante tiene demostrada utilidad en mieloma y linfomas permitiendo recuperar la hematopoyesis luego de quimioterapias de alta intensidad. El alotrasplante permite reemplazar hematopoyesis defectuosa y/o introducir un potente efecto inmunológico llamado "efecto de injerto contra tumor". En los últimos años, se han desarrollado nuevos fármacos que permiten optimizar la recolección de progenitores autólogos y se han modificado los esquemas de trasplante, permitiendo un uso más amplio. El haplo trasplante alogénico ha favorecido que los enfermos tengan mejores posibilidades de encontrar donantes. En esta revisión, se analizan brevemente estas nuevas modalidades adoptadas en nuestro programa de trasplante hematopoyético.(AU)


Hematopoietic transplantation offers cure or control in several benign or malignant diseases. Autologous transplantation has proven to be useful in myeloma and lymphoma patients allowing hematopoiesis recovery after high-intensity chemotherapies. Allogeneic transplantation can replace defective hematopoiesis and / or introduce graft-versus-tumor effect. In recent years, new strategies have been developed to optimize autologous progenitor's collection and haploidentical modalities have allowed a wider use of allotransplants. In this brief review these new modalities adopted in our program are analyzed.(AU)


Subject(s)
Humans , Male , Female , Transplantation , Transplantation, Autologous , Transplantation, Haploidentical , Hematopoietic System
14.
Chinese Journal of Hematology ; (12): 321-325, 2015.
Article in Chinese | WPRIM | ID: wpr-282041

ABSTRACT

<p><b>OBJECTIVE</b>To explore the protection function of rapamycin in hematopoietic system damage induced by irradiation.</p><p><b>METHODS</b>Six to eight week old C57BL/6J male mice were used for experiment. Mice received 4 mg/kg rapamycin by i.p.injection every other day for 5 times. The day after the last injection, mice were exposed to a dose (5 Gy) of total body irradiation (TBI). Peripheral blood was measured by a complete blood count at 0.5, 1, 2, 3, 5, 7, 40, 70 days after TBI. The hematoxylin-eosin staining was used to observe the pathologic changes in sternum obtained from mice at day 5 after TBI. CFU-S of spleen was measured by immerging in Tellyesniczky solution for 24 h at day 5 after TBI.</p><p><b>RESULTS</b>Before TBI, WBC and LYM decreased in rapamycin-treated mice compared with control (P<0.01); RBC and HGB increased (P<0.05); there was no difference in PLT; HE staining of bone marrow from rapamcin-treated and control mice before irradiation showed no difference in marrow cellularity. After TBI, WBC and LYM decreased significantly, with no difference at 0.5 d to 7 d between rapamycin-treated and control. The counts of WBC and LYM in rapamycin-treated mice restored to normal at 40 d and 70 d. RBC and HGB decreased at irradiation group at 3 d to 7 d, but rapamycin stimulated them to a higher level, both of them tended to normal at 40 d and 70 d. HE staining of bone marrow after 5 day of 5 Gy irradiation, nucleated cells in control decreased significantly, but restored in rapamycin-treated mice. CFU-S results showed the colony number in rapamycin-treated mice was much higher than control mice after 5 Gy irradiation, with 40.00±12.86 and 13.20±2.31 (P=0.035), respectively.</p><p><b>CONCLUSION</b>Administration of rapamycin to mice before irradiation protected the mice from hematopoietic damage induced by irradiation by maintaining the bone marrow nucleated cells, slowing down decrease and promoting the restoration of peripheral blood cells and protecting hematopoitic stem/progenitor cells in spleen.</p>


Subject(s)
Animals , Blood Cell Count , Blood Cells , Bone Marrow , Bone Marrow Cells , Hematopoietic System , Male , Mice , Mice, Inbred C57BL , Sirolimus , Spleen , Whole-Body Irradiation
15.
Article in English | WPRIM | ID: wpr-171263

ABSTRACT

Self-renewal and differentiation are hallmarks of stem cells and controlled by various intrinsic and extrinsic factors. Increasing evidence indicates that estrogen (E2), the primary female sex hormone, is involved in regulating the proliferation and lineage commitment of adult and pluripotent stem cells as well as modulating the stem cell niche. Thus, a detailed understanding of the role of E2 in behavior of stem cells may help to improve their therapeutic potential. Recently, it has been reported that E2 promotes cell cycle activity of hematopoietic stem and progenitor cells and induces them to megakaryocyte-erythroid progenitors during pregnancy. This study paves the way towards a previously unexplored endocrine mechanism that controls stem cell behavior. In this review, we will focus on the scientific findings regarding the regulatory effects of E2 on the hematopoietic system including its microenvironment.


Subject(s)
Adult , Cell Cycle , Estrogens , Female , Hematopoiesis , Hematopoietic Stem Cells , Hematopoietic System , Humans , Megakaryocyte-Erythroid Progenitor Cells , Pluripotent Stem Cells , Pregnancy , Stem Cell Niche , Stem Cells
16.
Article in English | WPRIM | ID: wpr-52284

ABSTRACT

Lead, which is widely used in industry, is a common element found in low concentrations in the Earth's crust. Implementations to reduce environmental lead concentrations have resulted in a considerable reduction of lead levels in the environment (air) and a sustained reduction in the blood lead levels of the average citizen. However, people are still being exposed to lead through a variety of routes in everyday commodities. Lead causes health problems such as toxicity of the liver, kidneys, hematopoietic system, and nervous system. Having a carcinogenic risk as well, the IARC classifies inorganic lead compounds as probably carcinogenic to humans (Group 2A). Occupational lead poisonings have decreased due to the efforts to reduce the lead concentrations in the working environment. In contrast, health hazards associated with long-term environmental exposure to low concentrations of lead have been reported steadily. In particular, chronic exposure to low concentrations of lead has been reported to induce cognitive behavioral disturbances in children. It is almost impossible to remove lead completely from the human body, and it is not easy to treat health hazards due to lead exposure. Therefore, reduction and prevention of lead exposure are very important. We reviewed the toxicity and health hazards, monitoring and evaluation, and management of lead exposure.


Subject(s)
Antioxidants , Child , Environmental Exposure , Hematopoietic System , Human Body , Humans , Kidney , Lead Poisoning , Liver , Nervous System
17.
Rev. bras. hematol. hemoter ; 36(2): 147-151, Mar-Apr/2014.
Article in English | LILACS | ID: lil-710190

ABSTRACT

Bone marrow is organized in specialized microenvironments known as 'marrow niches'. These are important for the maintenance of stem cells and their hematopoietic progenitors whose homeostasis also depends on other cell types present in the tissue. Extrinsic factors, such as infection and inflammatory states, may affect this system by causing cytokine dysregulation (imbalance in cytokine production) and changes in cell proliferation and self-renewal rates, and may also induce changes in the metabolism and cell cycle. Known to relate to chronic inflammation, obesity is responsible for systemic changes that are best studied in the cardiovascular system. Little is known regarding the changes in the hematopoietic system induced by the inflammatory state carried by obesity or the cell and molecular mechanisms involved. The understanding of the biological behavior of hematopoietic stem cells under obesity-induced chronic inflammation could help elucidate the pathophysiological mechanisms involved in other inflammatory processes, such as neoplastic diseases and bone marrow failure syndromes.


Subject(s)
Humans , Hematopoietic System , Inflammation , Obesity
18.
Article in Chinese | WPRIM | ID: wpr-349697

ABSTRACT

The aim of this study was to investigate the effects of D-methionine (D-met) on the hematopoietic system injury in irradiated mice. C57BL/6 mice were divided into control group, irradiated group, 300 mg/kg D-met plus irradiation group and 1000 mg/kg D-met plus irradiation group. The control mice received sham irradiation, and the mice in remainder groups were exposed to 7.5 Gy; 1,4,8 Gy and 1 Gy of (137)Cs γ-ray respectively, were used to detect the survival rate, survival rate of bone marrow cells, WBC and its differential counts as well the colony formation ability in irradiated mice, respectively. The D-met was intraperitoneally injected to mice at 30 min before irradiation. The results showed that 300 and 1000 mg/kd D-met did not obviously enhance the survival rate of mice exposed to 7.5 Gy; the 10(-2),10(-3),10(-4) mol/L D-met significantly increased the survival rate of bone marrow cells in mice exposed to 1,4,8 Gy; 300 and 1000 mg/kg D-met even so increased the WBC count of peripheral blood in mice exposed to 1 Gy, but there was no statistical difference as compared with irradiated alone mice, moreover 300 and 1000 mg/kg D-met could obviously promote the colony formation ability of bone marrow cells in irradiated mice, the CFU-GM count was higher than that in 1 Gy irradiated mice (P < 0.05). It is concluded that the D-met can effectively mitigate the marrow cell injury resulted from irradiation, enhance the survival rate of bone marrow cells in irradiated mice, promote the recovery of hematopoietic function from radiation injury in mice.


Subject(s)
Animals , Bone Marrow Cells , Radiation Effects , Hematopoietic System , Radiation Effects , Leukocyte Count , Methionine , Pharmacology , Mice , Mice, Inbred C57BL , Radiation Injuries
19.
Journal of Experimental Hematology ; (6): 1525-1530, 2014.
Article in Chinese | WPRIM | ID: wpr-340465

ABSTRACT

Normal hematopoietic B progenitor cells are similar with acute B lymphoblastic leukemia (ALL) cells in terms of morphology and immunophenotypes which easily result in misdiagnosis of diseases. This study was purposed to explore the importance of B progenitor cell (BPC) level in differential diagnosis of hematologic diseases. A total of 664 specimens including 87 specimens from patients with non-malignant hematologic diseases as control and 577 specimens from AL patients in different progressive stage were analyzed. Out of 577 specimens 26 were collected from ALL patients, 261 were collected from B-ALL, 290 were collected from AML. The relation of different clinical status (new diagnosis, remission, relapse), age and degree of leukemia cell involvement with hematopoietic BPC level were analyzed through identification of CD34/CD10/CD19/CD45 antibody combination and quantification of hematopoietic BPC. The results indicated that (1) CD45 distributed from positive to weak positive, and with very low side scatter. The early hematopoietic BPC expressed CD34⁺, along with increasing of cell maturation, the CD34 expression gradually disappeared, while CD19 and CD10 showed positive in whole stage of hemaropoietic BPC, and early CD10 highly was expressed. (2) the mean percentage of hematopoietic BPC was 1.36% in control group, 0.60% in T-ALL, 1.39% in B-ALL and 0.80% in AML; the detected rate of hematopoietic BPC in control, T-ALL, B-ALL and AML were 87.4%, 61.5%, 83.5%, 75.9%, respectively; the mean percentage of hematopoietic BPC was 0.37% at new diagnosis, 1.66% in remission and 0.55% in relapse. (3) along with increase of age, the hematopoietic BPC level generally disclined. (4) specimens >5% hematopoietic BPC were mainly found in remission stage of leukemia patients. It is concluded that the hematopoietic BPC are present in malignant and non-malignant hematologic diseases. The changes of hematopoietic BPC level correlate with disease state, age and leukemia cell involvement. The increased hematopoietic BPC level are observed most often in the patients with remission after themotherapy. It should be carefully to diagnose and discriminate between malignant and benign cells with double positive CD19 and CD10. Use of multiparametric flow cytometry and optimal antibody combination are important for discriminating hematopoietic BPC from minor residual disease and accuratly diagnosing diseases and evaluating curative effectiveness.


Subject(s)
Acute Disease , Cell Differentiation , Flow Cytometry , Hematopoietic System , Humans , Immunophenotyping , Leukemia , Pathology , Neoplasm Recurrence, Local , Neoplasm, Residual , Precursor Cells, B-Lymphoid , Pathology
20.
Journal of Experimental Hematology ; (6): 1673-1677, 2014.
Article in Chinese | WPRIM | ID: wpr-340438

ABSTRACT

The study was aimed to investigate the effect of anti-mouse CD122 antibody on the hematopoietic repopulating capacity of cord blood CD34⁺ cells in a humanized murine model-non obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. After sublethal irradiation with γ-ray, NOD/SCID mice were intraperitoneally injected with 200 µg mouse isotype control antibody or anti-mouse CD122 antibody. Human cord blood CD34⁺ cells or phosphate-buffered saline (PBS) were injected via the tail vein at 6-8 hours later. Cohort of the mice injected with anti-mice CD122 antibody or control antibody alone were sacrificed at different time point (at week 2, 3, and 4 weeks) after the injection, and the percentage of NK cells in the peripheral blood was analyzed by flow cytometry. To evaluate the effect of anti-mouse CD122 antibody on the repopulating capacity of cord blood CD34⁺ cells in the recipient mice, phenotype analysis was performed in the bone marrow at 6 and 8 weeks after the transplantation. The results showed that the proportion of NK cells in the peripheral blood were (4.6 ± 0.6)% and (5.7 ± 1.7)% at week 2 and 3 after anti-CD122 antibody injection respectively,which decreased by 60%, compared with the mice injected with isotype control antibody. After 6 and 8 weeks of cord blood CD34⁺ cell transplantation,the percentage of human CD45⁺ in the bone marrow of the recipient mice treated with anti-mice CD122 antibody was (63.0 ± 12.2)% and (53.2 ± 16.3)%,respectively,which were dramatically higher than that in the mice treated with isotype control antibody (7.7 ± 3.6)% and (6.1 ± 2.4)%. Moreover,at 8 weeks after transplantation,human CD34⁺ cells appeared significantly in the recipients treated with anti-CD122 antibody. It is concluded that the anti-mouse CD122 antibody enhances the hematopoietic repopulating capacity of cord blood CD34⁺ cells in the NOD/SCID mice through decreasing the proportion of NK cells.


Subject(s)
Animals , Antibodies , Allergy and Immunology , Antigens, CD34 , Bone Marrow , Cord Blood Stem Cell Transplantation , Fetal Blood , Allergy and Immunology , Hematopoietic Stem Cell Transplantation , Hematopoietic System , Cell Biology , Allergy and Immunology , Humans , Interleukin-2 Receptor beta Subunit , Allergy and Immunology , Killer Cells, Natural , Mice , Mice, Inbred NOD , Mice, SCID , Transplantation, Heterologous
SELECTION OF CITATIONS
SEARCH DETAIL